Skip to main content
TipRanks
Go Ultimate75% OFF

Gregory Todd Bosch Insider Profile

4 Followers

Gregory Todd Bosch, former Chief Executive at Realm Therapeutics, holds 180.00K shares in Realm Therapeutics (Ticker: GB:RLM). Most recently, Gregory Todd Bosch Bought 100,000 shares of Realm Therapeutics on Feb 03, 2012 for an estimated value of 65.00K .

Gregory Todd Bosch's Trading History

RLM
Realm Therapeutics
Feb 03, 2012―Informative Buy65.00K£20.70K
GB:RLM
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Feb 03, 2012Informative Buy£65.00K100,000£65.00-36.60%―
Feb 10, 2009Informative Buy£14.16K200,000£7.00+44.50%―
Jan 02, 2009Informative Buy£7.50K100,000£8.00+53.50%―

You May Also Like

Gregory Todd Bosch insider profile FAQ

What is the percentage of profitable transactions made by Gregory Todd Bosch?
The percentage of profitable transactions made by Gregory Todd Bosch is 67%.
What is the average return per transaction made by Gregory Todd Bosch?
The average return per transaction made by Gregory Todd Bosch is 20.40%.
What stocks does Gregory Todd Bosch hold?
Gregory Todd Bosch holds: GB:RLM stocks.
What was Gregory Todd Bosch’s latest transaction?
Gregory Todd Bosch’s latest transaction was an Informative Buy of 65.00K .
What was Gregory Todd Bosch's most profitable transaction?
Gregory Todd Bosch’s most profitable transaction was an Informative Buy of GB:RLM stock on January 2, 2009. The return on the trade was 53.50%.
What is Gregory Todd Bosch's role in Realm Therapeutics?
Gregory Todd Bosch's role in Realm Therapeutics is Chief Executive.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.